Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,853-3,864 of 4,306
Drug study icon
CompletedNCT04158453

Safety, Blood Levels and Effects of AUT00201

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Autifony Therapeutics Limited
Condition
Schizophrenia
Drug study icon
CompletedNCT02589262

Safety, Blood Levels and Effects of AUT00206

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Autifony Therapeutics Limited
Condition
Schizophrenia
Drug study icon
CompletedNCT00447941

Safety, PK and PD Study in Healthy Male Japanese Subjects

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 45 Years
Countries
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Condition
Schizophrenia
Drug study icon
CompletedNCT00743405

Safety study of GSK1034702 in Schizophrenia

This study is completed in the United Kingdom. It is testing GSK1034702 for Schizophrenia.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Drug study icon
CompletedNCT01348100

Safety study of iloperidone Depot in Schizophrenia

This study is completed in the United States. It is testing iloperidone Depot for Schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT02331433

Safety study of Single Doses of APN1125 in Schizophrenia

This study is completed in the United States. It is testing Single Doses of APN1125 for Schizophrenia.

In Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
CoMentis
Condition
Schizophrenia
Biological study icon
TerminatedNCT02841358

Screening of Niemann-Pick Disease, Type C in a Psychiatric Population

This summary needs review. Please check the official study record and contact the research team for details.

In La Tronche
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiologicalOver 18 Years
Countries
France
Sponsor
University Hospital, Grenoble
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04611737

Self-Determination Theory and Motivational Interviewing

This summary needs review. Please check the official study record and contact the research team for details.

In Kaohsiung City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 20 Years to 80 Years
Countries
Taiwan
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02474524

Self-Management and Recovery Technology Psychosocial Intervention study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Eastern Melbourne
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Swinburne University of Technology
Condition
Schizophrenia
Drug study icon
CompletedNCT00214578

Seroquel on Glucose Metabolism

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Burgas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom, Bulgaria, Czechia, ...
Sponsor
AstraZeneca
Condition
Schizophrenia
Other study type icon
CompletedNCT00951418

Serum Clozapine and Cognition

This summary needs review. Please check the official study record and contact the research team for details.

In Aalborg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Denmark
Sponsor
University of Aarhus
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.